Cargando…
Use of Intralesional Deoxycholic Acid for Antiretroviral Treatment Associated Lipohypertrophy: A Qualitative Open-Label Study of an Innovative Indication
BACKGROUND: With the advent of antiretroviral treatment (ART), human immunodeficiency virus/AIDS has become a chronic manageable disease. Though life expectancy has improved, it brings alongside effects of long-term medical treatment. One of the major side effects is body dysmorphism, which leads to...
Autores principales: | Kulkarni, Vinay, Salunke, Tejaswini S, Mandhane, Ambarish G, Vaidya, Pradyumna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405548/ https://www.ncbi.nlm.nih.gov/pubmed/37554685 http://dx.doi.org/10.4103/JCAS.JCAS_150_22 |
Ejemplares similares
-
Lesion reduction with intralesional deoxycholic acid in Dercum disease with radiographic evidence
por: Rice, Shauna, et al.
Publicado: (2021) -
Intralesional deoxycholic acid: A potential therapeutic alternative for the treatment of lipomas arising in the face
por: Santiago-Vázquez, Marely, et al.
Publicado: (2021) -
Insulin lipodystrophy and lipohypertrophy
por: Mokta, Jatinder K., et al.
Publicado: (2013) -
Lipoatrophy/lipohypertrophy outcomes after antiretroviral therapy switch in children in the UK/Ireland
por: Innes, Steve, et al.
Publicado: (2018) -
Lipohypertrophy and metabolic disorders in HIV patients on antiretroviral therapy: a systematic multidisciplinary clinical approach
por: Sculier, Delphine, et al.
Publicado: (2014)